EDSA (Edesa Biotech Inc) Sof foyda

EDSA (Edesa Biotech) - kompaniyaning tovar belgisi

Yallig'lanishga qarshi vositalarning so'nggi bosqichli sinovlarini yakunlashga e'tibor qaratgan barqaror boshqaruv Edesa Biotech, Inc. (EDSA) uchun ijobiy fon yaratadi. Kompaniyaning tijorat natijalari ushbu tendentsiyani tasdiqlaydi, bunda -0.01 qiymati metrika darajasini ifodalaydi. O'sish EB05 dori vositasining muvaffaqiyati va uning ishlanmalarining orfan maqomiga ega ekanligi bilan ta'minlanmoqda, operatsion samaradorlik esa ixtisoslashtirilgan sovuq zanjir logistikasi va tadqiqot markazlarining diversifikatsiyasi orqali saqlanib qolmoqda.

EDSA (Edesa Biotech, Inc.) Sof foyda tarixi 04.07.2022dan 30.10.2026gacha

Edesa Biotech (EDSA) kompaniyasining tahliliy kesimlari va maʼlumotlar hisoboti

- narx va narxlar bo'yicha konsensus prognoz:
Aksiya kotirovkalari Edesa Biotech Corp|EDSA - Tahlilchilar konsensus prognozi
- biznesning bozor baholash ko'rsatkichlari:
Bozor kapitallashuvi Edesa Biotech Corp|EDSA - Kompaniyani butunlay sotib olishdagi haqiqiy narx
- balans kapitallashuvi bo'yicha ma'lumotlar:
Aksiyaning buxgalteriya qiymati Edesa Biotech|EDSA - Balans kapitallashuvi|Balans qiymatiga nisbatan bozor kapitallashuvi edesabiotech.com|EDSA - Kompaniyaning jami aktivlari
- qarzlar va to'lov qobiliyati haqida ma'lumot:
Umumiy qarzning xususiy kapitalga nisbati Edesa Biotech, Inc.|EDSA - Uzoq muddatli qarzning o'z kapitaliga nisbati|Qisqa muddatli qarzning o'z kapitaliga nisbati Edesa Biotech Inc|EDSA - Kompaniyaning umumiy qarzi|Balans kapitallashuviga qarzlar Edesa Biotech Corp|EDSA - Kompaniyaning uzoq muddatli qarzi|Kompaniyaning qisqa muddatli qarzdorligi Edesa Biotech|Shoshilinch likvidlik edesabiotech.com
- sof daromad va qiymat multiplikatorlari ko'rsatkichlari:
EDSA - Sof foyda
Kompaniyaning jamlanma tahlili:Edesa Biotech, Inc.
Edesa asosiy tovari

Edesa Biotech, Inc. (EDSA) kompaniyasidagi samarali sovuq zanjir logistikasi va hablar diversifikatsiyasi yuqori operatsion daromadlilikni ta'minlab, sof foydaga bevosita ta'sir ko'rsatmoqda. Kompaniyaning foyda darajalarini tahlil qilish barcha xarajatlardan keyingi sof naqd pul balansini baholash imkonini beradi, bunda grafikdagi keskin pasayishlarning yo'qligi pul oqimi bo'shliqlari mavjud emasligini va biznesning fundamental barqarorligini tasdiqlaydi.

Asosiy raqobatchilar

Sof daromad argenx BVBA|BNTX (BioNTech SE) - Sof foyda|Sof foyda Abivax Pharma|Sof daromad ADMA (ADMA Biologics, Inc.)|PTGX (Protagonist Therapeutics, Inc.) - Yakuniy foyda|Sof foyda IMVT (Immunovant Corp)|Sof moliyaviy natija Kiniksa Corp (KNSA)|GRFS - Kompaniyaning sof foydasi|adaptivebiotech.com (ADPT) - Sof daromad|Celldex Therapeutics, Inc. (CLDX) - Kompaniyaning sof foydasi|Sof daromad Aurinia Pharmaceuticals Inc|Sof daromad BCRX|Sof foyda Vera Corp|Kompaniyaning sof foydasi Dianthus Therapeutics (DNTH)|pharvaris.com - Kompaniya foydasi|Sof foyda ABCL (AbCellera Biologics Inc)|Tourmaline Bio Inc (TRML) - Kompaniyaning sof daromadi|Intrexon - Sof foyda|Kompaniyaning sof daromadi Pharming Corp|NKTR: Sof foyda|Kompaniya foydasi UPB|ZBIO (Zenas Biopharma) - Sof foyda|Kompaniyaning sof daromadi Immunome Inc IMNM|Kompaniyaning sof foydasi Gossamer Corp (GOSS)|Sof moliyaviy natija KalVista Corp|Sof foyda SEPN (Septerna Inc)|Sof foyda pieris.com PVLA|SVRA: Sof daromad|Yakuniy foyda RIGL (Rigel Pharma)|ANAB: Sof foyda|ATXS (Astria Corp) - Kompaniyaning sof foydasi|ENGN (enGene Holdings Inc.) - Sof foyda|rapt.com (RAPT) - Sof moliyaviy natija|Kompaniyaning sof foydasi Aerovate Therapeutics Inc (JBIO)|ACRS - Kompaniyaning sof daromadi|Kyverna - Sof daromad|Soliqlar to‘langandan keyingi foyda TLSA (Tiziana Life Sciences, Ltd.)|Cabaletta Bio, Inc. - Sof foyda|Kompaniyaning sof daromadi ventyxbio.com|THTX: Sof foyda|Sof daromad Avalo Therapeutics, Inc.|ELDN (Eledon) - Sof foyda|AGEN: Yakuniy foyda|Sof daromad CLYM (Climb Bio Inc)|ZURA (zurabio.com) - Yakuniy foyda|Sof foyda ATYR (aTyr Pharma)|Sof moliyaviy natija Adagene Inc (ADAG)|IMA - Kompaniyaning sof foydasi|STTK (Shattuck Labs, Inc.) - Kompaniya foydasi|EQ: Sof foyda|Sof daromad Connect Biopharma Holdings Limited|Sof daromad IMUX|Atara Biotherapeutics Inc (ATRA) - Sof moliyaviy natija|Sof foyda IFRX|XFOR - Kompaniyaning sof daromadi|Sof foyda ACET (Adicet Bio, Inc.)|CELU: Kompaniya foydasi|INMB - Kompaniyaning sof foydasi|Sof moliyaviy natija Barinthus Biotherapeutics PLC BRNS|KZR: Sof foyda|SAB Biotherapeutics Inc (SABS) - Sof foyda|Kompaniyaning sof foydasi Akari Therapeutics|Enlivex Therapeutics, Ltd. - Soliqdan keyingi foyda|Sof foyda QTTB|GOVX (GeoVax Labs) - Yakuniy foyda|Sof foyda IBIO (iBio Corp)|Sof foyda Carisma Therapeutics Inc CARM|XTLB - Kompaniyaning sof foydasi|Yakuniy foyda BOLT (Bolt Biotherapeutics)|hcwbiologics.com (HCWB) - Kompaniyaning sof foydasi|Sof daromad Aptevo Therapeutics Inc.|AIM (AIM ImmunoTech) - Sof foyda|Sof foyda Aditxt Corp|Sof daromad GRI (GRI Bio, Inc.)|XRTX (xortx.com) - Yakuniy foyda|Sof foyda HIND (Vyome Holdings)|Sof moliyaviy natija Revelation Biosciences Inc (REVB)|INDP - Kompaniyaning sof foydasi|BiondVax Pharmaceuticals (SCNI) - Sof daromad|calcimedica.com (CALI) - Kompaniyaning sof foydasi|Sof daromad Affimed N.V.|Sof daromad ALLK|Sof foyda HOOKIPA|Kompaniyaning sof foydasi IGM Biosciences, Inc. (IGMS)|iTeos Pharma - Kompaniya foydasi|Sof foyda OCEA (Ocean Biomedical, Inc.)|tcbiopharm.com (TCBP) - Kompaniyaning sof daromadi|Third Harmonic Bio, Inc. - Sof foyda